Y. Torrens

2.6k total citations
65 papers, 2.2k citations indexed

About

Y. Torrens is a scholar working on Cellular and Molecular Neuroscience, Molecular Biology and Psychiatry and Mental health. According to data from OpenAlex, Y. Torrens has authored 65 papers receiving a total of 2.2k indexed citations (citations by other indexed papers that have themselves been cited), including 54 papers in Cellular and Molecular Neuroscience, 47 papers in Molecular Biology and 9 papers in Psychiatry and Mental health. Recurrent topics in Y. Torrens's work include Neuropeptides and Animal Physiology (46 papers), Receptor Mechanisms and Signaling (41 papers) and Chemical Synthesis and Analysis (11 papers). Y. Torrens is often cited by papers focused on Neuropeptides and Animal Physiology (46 papers), Receptor Mechanisms and Signaling (41 papers) and Chemical Synthesis and Analysis (11 papers). Y. Torrens collaborates with scholars based in France, United States and Canada. Y. Torrens's co-authors include J. Głowiński, Monique Saffroy, Jean‐Claude Beaujouan, J. C. Beaujouan, Jacques Glowinski, Solange Lavielle, Antoinette Viger, Gérard Chassaing, Lena Bergström and François Petitet and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of Neuroscience and Brain Research.

In The Last Decade

Y. Torrens

64 papers receiving 2.1k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Y. Torrens France 31 1.8k 1.6k 320 177 173 65 2.2k
J. C. Beaujouan France 23 1.4k 0.7× 1.2k 0.7× 221 0.7× 130 0.7× 123 0.7× 42 1.6k
C. Garret France 24 1.2k 0.7× 926 0.6× 404 1.3× 122 0.7× 190 1.1× 59 1.6k
Monique Saffroy France 25 1.5k 0.8× 1.3k 0.8× 247 0.8× 195 1.1× 154 0.9× 52 1.7k
A R Wakade United States 29 1.2k 0.7× 1.3k 0.9× 382 1.2× 167 0.9× 43 0.2× 55 2.0k
Jean‐Claude Beaujouan France 21 1.0k 0.6× 880 0.6× 196 0.6× 119 0.7× 101 0.6× 34 1.2k
Didier Pélaprat France 29 1.5k 0.8× 1.3k 0.8× 167 0.5× 98 0.6× 51 0.3× 72 2.3k
Danielle Gully France 21 1.2k 0.7× 1.1k 0.7× 191 0.6× 139 0.8× 94 0.5× 28 1.7k
I.J.M. Beresford United Kingdom 19 743 0.4× 627 0.4× 299 0.9× 148 0.8× 239 1.4× 36 1.3k
Mirek Jurzak Belgium 22 786 0.4× 817 0.5× 193 0.6× 188 1.1× 80 0.5× 40 1.5k
Michael Rigby United Kingdom 18 986 0.5× 1.0k 0.7× 651 2.0× 53 0.3× 114 0.7× 27 1.9k

Countries citing papers authored by Y. Torrens

Since Specialization
Citations

This map shows the geographic impact of Y. Torrens's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Y. Torrens with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Y. Torrens more than expected).

Fields of papers citing papers by Y. Torrens

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Y. Torrens. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Y. Torrens. The network helps show where Y. Torrens may publish in the future.

Co-authorship network of co-authors of Y. Torrens

This figure shows the co-authorship network connecting the top 25 collaborators of Y. Torrens. A scholar is included among the top collaborators of Y. Torrens based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Y. Torrens. Y. Torrens is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Lanteri, Christophe, Lucas Salomon, E. Doucet, et al.. (2009). Inhibition of Monoamine Oxidases Desensitizes 5-HT1AAutoreceptors and Allows Nicotine to Induce a Neurochemical and Behavioral Sensitization. Journal of Neuroscience. 29(4). 987–997. 22 indexed citations
2.
Tassin, Jean‐Pol, Y. Torrens, Lucas Salomon, Christophe Lanteri, & Philip Seeman. (2007). Elevated dopamine D2High receptors in α‐1b‐adrenoceptor knockout supersensitive mice. Synapse. 61(7). 569–572. 4 indexed citations
3.
Lanteri, Christophe, Lucas Salomon, Y. Torrens, Jacques Glowinski, & Jean‐Pol Tassin. (2007). Drugs of Abuse Specifically Sensitize Noradrenergic and Serotonergic Neurons Via a Non-Dopaminergic Mechanism. Neuropsychopharmacology. 33(7). 1724–1734. 77 indexed citations
4.
Bretin, Sylvie, Véronique Rogemond, Philippe Marin, et al.. (2006). Calpain product of WT‐CRMP2 reduces the amount of surface NR2B NMDA receptor subunit. Journal of Neurochemistry. 98(4). 1252–1265. 72 indexed citations
5.
Beaujouan, J. C., Monique Saffroy, Y. Torrens, & J. Głowiński. (2000). Different Subtypes of Tachykinin NK1 Receptor Binding Sites Are Present in the Rat Brain. Journal of Neurochemistry. 75(3). 1015–1026. 44 indexed citations
6.
Sagan, Sandrine, Laurent Venance, Y. Torrens, et al.. (1999). Anandamide and WIN 55212‐2 inhibit cyclic AMP formation through G‐protein‐coupled receptors distinct from CB1 cannabinoid receptors in cultured astrocytes. European Journal of Neuroscience. 11(2). 691–699. 74 indexed citations
7.
Torrens, Y., Jean‐Claude Beaujouan, Monique Saffroy, Jacques Glowinski, & Martine Tencé. (1998). Functional Coupling of the NK1 Tachykinin Receptor to Phospholipase D in Chinese Hamster Ovary Cells and Astrocytoma Cells. Journal of Neurochemistry. 70(5). 2091–2098. 17 indexed citations
8.
Torrens, Y., Monique Saffroy, J. Głowiński, & J. C. Beaujouan. (1997). Substance P(6–11) and natural tachykinins interact with septide-sensitive tachykinin receptors coupled to a phospholipase C in the rat urinary bladder. Neuropeptides. 31(3). 243–251. 15 indexed citations
9.
Beaujouan, Jean‐Claude, Monique Saffroy, Y. Torrens, & Jacques Glowinski. (1997). Potency and selectivity of the tachykinin NK3 receptor antagonist SR142801. European Journal of Pharmacology. 319(2-3). 307–316. 33 indexed citations
10.
Galli, Thierry, F. Artaud, Y. Torrens, et al.. (1994). NMDA and carbachol but not AMPA affect differently the release of [3H]GABA in striosome- and matrix-enriched areas of the rat striatum. Brain Research. 649(1-2). 243–252. 11 indexed citations
11.
Torrens, Y., Madison R. Dietl, J. C. Beaujouan, & J. Głowiński. (1991). Inhibitory effects of substance P and carbachol on the saturable sodium-dependent uptake process of myo-inositol in rat parotid gland.. Journal of Pharmacology and Experimental Therapeutics. 258(2). 639–646. 5 indexed citations
12.
Chassaing, Gérard, Solange Lavielle, A. Carruette, et al.. (1991). Selective agonists of NK-2 binding sites highly active on rat portal vein (NK-3 bioassay). Neuropeptides. 19(2). 91–95. 45 indexed citations
13.
Beaujouan, Jean‐Claude, B Teutsch, Monique Saffroy, et al.. (1991). NK-1 receptors are the only class of tachykinin receptors found on mouse cortical astrocytes. Peptides. 12(4). 813–820. 26 indexed citations
14.
Petitet, François, J. C. Beaujouan, Monique Saffroy, et al.. (1991). Further Demonstration that [Pro9]‐Substance P Is a Potent and Selective Ligand of NK‐1 Tachykinin Receptors. Journal of Neurochemistry. 56(3). 879–889. 32 indexed citations
15.
16.
Dietl, Madison R., Y. Torrens, J. C. Beaujouan, & J. Głowiński. (1989). Substance P‐Induced Reduction in the Initial Accumulation of Cytosolic myo‐[3H]Inositol in Rat Parotid Acinar Cells Mediated by the NK1 Tachykinin Receptor. Journal of Neurochemistry. 53(5). 1640–1643. 12 indexed citations
17.
Lavielle, Solange, Olivier Ploux, Sylviane Julien, et al.. (1988). Analysis of tachykinin binding site interactions using constrained analogues of tachykinins. Biochemical Pharmacology. 37(1). 41–49. 79 indexed citations
18.
19.
Lavielle, Solange, Gérard Chassaing, Sylviane Julien, et al.. (1986). Specific recognition of SP or NKB receptors by analogues of SP substituted at positions 8 and 9. European Journal of Pharmacology. 125(3). 461–462. 23 indexed citations
20.
Beaujouan, J. C., Y. Torrens, Antoinette Viger, & J. Głowiński. (1984). A new type of tachykinin binding site in the rat brain characterized by specific binding of a labeled eledoisin derivative.. Molecular Pharmacology. 26(2). 248–254. 94 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by J. C. Beaujouan Breakdown of academic impact, for papers by C. Garret Breakdown of academic impact, for papers by Monique Saffroy Breakdown of academic impact, for papers by A R Wakade Breakdown of academic impact, for papers by Jean‐Claude Beaujouan Breakdown of academic impact, for papers by Didier Pélaprat Breakdown of academic impact, for papers by Danielle Gully Breakdown of academic impact, for papers by I.J.M. Beresford Breakdown of academic impact, for papers by Mirek Jurzak Breakdown of academic impact, for papers by Michael Rigby
Rankless by CCL
2026